Puissance Life Science Opportunities Fund VI's Net Worth
-$11.1 Million
Who is Puissance Life Science Opportunities Fund VI?
Puissance Life Science Opportunities Fund VI does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Bellerophon Therapeutics, Inc., and Tracon Pharmaceuticals, Inc..
SEC CIK
Puissance Life Science Opportunities Fund VI's CIK is 0001760460
Past Insider Trading and Trends
2021 was Puissance Life Science Opportunities Fund VI's most active year for acquiring shares with 4 total transactions. Puissance Life Science Opportunities Fund VI's most active month to acquire stocks was the month of March. 2023 was Puissance Life Science Opportunities Fund VI's most active year for disposing of shares, totalling 3 transactions. Puissance Life Science Opportunities Fund VI's most active month to dispose stocks was the month of April. 2020 saw Puissance Life Science Opportunities Fund VI paying a total of $14,999,998.00 for 1,153,846 shares, this is the most they've acquired in one year. In 2023 Puissance Life Science Opportunities Fund VI cashed out on 1,771,262 shares for a total of $5,520,945.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Bellerophon Therapeutics, Inc. (BLPH) Snapshot price: $0.064
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.08M |
$0.10 | -$111,776.10 |
0
|
Oct 13
| |||
Form 4
| -11.10% | -134.42K |
$0.83 | -$111,569.43 | 1.08M |
Jun 7
| |||
Form 4
| -31.62% | -560.00K |
$9.46 | -$5,297,600.00 | 1.21M |
May 18
| |||
Form 4
| +0.46% | 8.19K |
$4.00 | $32,756.00 | 1.77M |
Jun 7
| |||
Form 4
| +52.80% | 609.23K |
$4.00 | $2,436,924.00 | 1.76M |
Apr 26
| |||
Form 4
|
∞
| 1.15M |
$13.00 | $14,999,998.00 | 1.15M |
May 21
| |||
| No matching records found | |||||||||
Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.1925
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
$1.17 | -$346.08 | 4.6M |
Nov 29
| |||
Form 4
| +0.19% | 8.65K |
$1.17 | $10,122.84 | 4.6M |
Nov 29
| |||
| No matching records found | |||||||||